limit tamoxifen use to 5 years
January 1996
The National Cancer Institute is now alerting oncologists to limit tamoxifen use to 5 years...for certain women being treated for early-stage breast cancer.
Taking tamoxifen for 5 years after lumpectomy or mastectomy significantly reduces the risk of recurrence and improves survival.
New evidence says that LONGER use doesn't further improve survival. It might even be detrimental...by increasing uterine cancer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote